Market for rheumatoid arthritis therapeutics estimated to reach over $6B in 2004

August 26, 2004 -- Research and Markets announces the addition of "Rheumatoid Arthritis Therapeutics" to its offerings.

Rheumatoid arthritis is a chronic autoimmune disorder characterized by joint swelling and pain, with joint erosion that may lead to disability. Since no cure is available yet, the goal of treatment has been to provide patients relief from the inflammation and pain, and to slow disease progression. Major current treatments include non - steroidal anti - inflammatories, traditional disease - modifying anti - rheumatic drugs, and biological response modifiers.

The market for rheumatoid arthritis therapeutics is estimated to reach over $6B in 2004 and growth will continue at a compound annual rate of 18.7% to reach approximately $15B worldwide in 2009. In 2009, segment distribution within the market will be COX - 2 inhibitors at 19% and biological response modifiers at 76%, with other drugs accounting for 5% of revenue.

Thisreport includes in - depth analysis of physician perspectives, incorporates company profiles, and assesses of the trends, challenges, and strategic options facing pharmaceutical companies operating in the rheumatoid arthritis space. In addition, thestudy provides financial models and the detailed assumptions used to determine major company market shares and the industry - wide revenue forecast.

For a thorough analysis of this important market, the report:
- highlights leading rheumatoid arthritis therapeutic products
- assesses results from a survey of 19 practicing rheumatologists and examines their views on current and emerging therapeutics and treatment trends
- provides a market forecast and revenue model from 2004 to 2009 with detailed assumptions for each therapeutic category and the industry as a whole
- analyzes the strategic positioning of eight emerging therapeutics
- profiles 14 pharmaceutical companies
- identifies multiple market trends and challenges
- provides strategic options for pharmaceutical companies looking to expand their revenues

For a complete index of this report click on http://www.researchandmarkets.com/reports/222276

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com




This article courtesy of http://www.yourarthritisguide.info.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Submit Your Article